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Background: Despite the well-known importance of cognitive deficits for everyday functioning in patients with
severe mental illness (SMI), evidence-based interventions directed at these problems are especially scarce for SMI
patients in long-term clinical facilities. Cognitive adaptation Training (CAT) is a compensatory approach that aims at
creating new routines in patients’ living environments through the use of environmental supports. Previous studies
on CAT showed that CAT is effective in improving everyday functioning in outpatients with schizophrenia. The aim
of this study is to evaluate the effect of CAT as a nursing intervention in SMI patients who reside in long-term
clinical facilities.
Methods/Design: This is a multicenter cluster randomized controlled trial comparing CAT (intervention group) as a
nursing intervention to treatment as usual (control group). The primary goal is to evaluate the effectiveness of CAT
on everyday functioning. Secondary outcomes are quality of life, empowerment and apathy. Further, an economic
evaluation will be performed. The study has a duration of one year, with four follow-up assessments at 15, 18, 21
and 24 months for the intervention group.
Discussion: There is a need for evidence-based interventions that contribute to the improvement of the functional
recovery of long-term residential patients. If our hypotheses are confirmed, it may be recommended to include CAT
in the guidelines for SMI care and to implement the method in standardized care.
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The term severe mental illness (SMI) defines a range of
psychiatric disorders, characterized by serious mental,
social and vocational problems that influence each other
and create a need for long-term continuous care by
mental health professionals [1]. The majority of the SMI
population suffers from schizophrenia or related psych-
otic disorders, which are characterized by positive symp-
toms (such as hallucinations and/or delusions), negative
symptoms (such as amotivation, social withdrawal and/
or blunted affect) and cognitive deficits (such as plan-
ning, memory and/or attention issues). Furthermore,
people with autism, obsessive compulsive disorder, per-
sonality disorder, bipolar disorder or major depression
are also considered to be suffering from SMI when they
follow a severe course of the illness [1]. In the
Netherlands, patients with SMI are admitted to long-
stay facilities when they are unable to live independently
and need more support than can be provided at assisted
or sheltered living facilities. Based on the most recent es-
timations, approximately 10% of the adult SMI population
is living in long-stay clinical facilities in the Netherlands
[1,2]. The degree of care dependency strongly relates to
everyday functioning [3], and is predicted by cognitive im-
pairments, common in the majority of SMI patients [4].
Despite the strong relationship between cognition and
everyday functioning, evidence-based interventions are
scarce, especially for those who reside in long-stay clinical
facilities. Two main approaches can be distinguished with
regard to interventions for cognitive problems in SMI: re-
storative and compensatory.
Restorative approaches, such as cognitive remediation,
aim to improve functional outcomes through enhanced
cognitive functioning. In cognitive remediation, people
are typically trained using computer training software.
Cognitive remediation techniques have been extensively
studied and though they attain small positive effects on
cognition, recent (meta-analytic) studies demonstrated
that these improvements do not generalize to functional
improvements [5,6]. Significant and larger effect sizes
are achieved when cognitive remediation is combined
with some form of rehabilitation program, which ques-
tions the specific therapeutic effects of cognitive remedi-
ation programs on global and real-world functioning [5,6].
Compensatory approaches do not aim to improve cog-
nitive functions per se. Instead, they aim to bypass the
cognitive deficits that hinder patients in performing their
activities of daily living. Cognitive adaptation training
(CAT) is such an approach [7,8]. CAT is an in-home
intervention that targets real-world problems in a real-
world setting, namely the patient’s own living environ-
ment. With the use of environmental supports, the
patient is taught new routines that appeal less to cogni-
tive functions. Furthermore, CAT interventions arestrongly individualized, taking into account the specific
problems in activities of daily living of the individual pa-
tient. Effects of CAT include improvements in everyday
functioning, quality of life, medication adherence and re-
lapse in outpatients with schizophrenia [7-9].
CAT starts with composing an individually tailored
treatment plan, based on the patient’s specific problems
with respect to behavior, cognitive or executive function-
ing and everyday functioning. If the patient’s behavior
type is predominantly characterized by apathy (amotiva-
tion, lack of initiative and/or lack of goal-directed behav-
ior), compensation strategies will focus on cueing and
prompting behavior. Patients whose behavior is predom-
inantly characterized by disinhibition (easily distracted
by irrelevant stimuli and/or behaving inappropriate in a
situation) may benefit from removal of distracting stimuli.
For patients with a mixed behavior type, both intervention
strategies can be used. The form of the intervention is
based on the level of executive functioning of the patient
(such as planning, goal-directed behavior and mental flexi-
bility). Interventions for patients with poor executive func-
tioning are more easily noticeable (for example, larger
signs), more specific (for example, stepwise instructions)
and more numerous, compared to interventions for pa-
tients with fair executive functioning, which can be more
subtle (for example, smaller signs) and less specific (for ex-
ample, global instructions).
Information about the patient’s cognitive strengths and
weaknesses in attention and memory is used to further
individualize the interventions. For example, if a patient
has strong visual attention but their auditory attention is
weak, they would probably benefit more from visual cues
and/or signs than from verbal reminders. The specific in-
dividual problems in everyday functioning determine the
individual goals at which the interventions are directed.
Commonly used environmental supports are watches, cal-
endars, electronic devices, signs, household supplies (such
as boxes and cleaning supplies) and means of transporta-
tion (for example, the bus or a taxi pass). A CAT manual
includes examples of specific environmental supports for
16 domains of daily living [10], and was slightly adapted
(by authors APMS and PQ) for practical use by psychiatric
nurses.
Despite the well-established effectiveness of CAT for
outpatients, it remains unclear whether long-term resi-
dential patients can benefit from CAT in a similar way.
In this population, the cognitive and functional deficits
can be considered to be most severe. Therefore, CAT
may bridge the gap between the current knowledge
about these deficits and the lack of evidence-based inter-
ventions for this patient group. At the same time, long-
stay facilities may be better able to deal with the need
for ongoing support, which is necessary to maintain the
functional improvements made with CAT [9,11].
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port is often provided by psychiatric nurses. Supporting
patients in performing everyday tasks is part of their
daily working routine. While in previous studies CAT
was delivered by psychologists with a minimum of a
bachelor’s level education, the current study aims to
train psychiatric nurses for CAT. Involving nurses
should integrate CAT in the daily working routine and
thereby provide the continuous support which is neces-
sary to sustain improvements that are made with CAT.
A pilot study conducted by our group provided tentative
evidence that CAT as a nursing intervention can im-
prove everyday functioning in long-term residential pa-
tients in the Netherlands [12]. Furthermore, a recent
Canadian study demonstrated that case manager support
can sustain CAT interventions after a period of CAT-
specialized intervention [13].
The abovementioned studies only included patients with
a diagnosis in the schizophrenia spectrum, which leaves
the effect of CAT on SMI patients with a different diagno-
sis unknown. However, cognitive impairments are also
present in patients with other psychiatric disorders [14].
Therefore we expect that SMI patients with cognitive defi-
cits, but without the psychotic symptoms that characterize
schizophrenia, may similarly benefit from CAT.
The primary goal of the current study is to assess the
effect of CAT as a nursing intervention on everyday
functioning in long-term residential patients with SMI.
The secondary goals are to evaluate the effect of CAT
on quality of life, empowerment and apathy. Follow-up
measurements will be conducted to evaluate whether
obtained effects on primary and secondary outcome
measures can be retained, as well as to evaluate the
feasibility of integrating CAT support into the daily
working routine of the nurses. We expect CAT as a
nursing intervention to lead to improvements in every-
day functioning and apathy, and thereby an improved
quality of life for patients with SMI. As CAT is not de-
signed to alter cognitive functioning (rather to bypass
cognitive problems) or to improve positive symptoms,
we do not expect these to change. Finally, we will assess
the long-term cost-effectiveness and cost-utility of the
intervention. Importantly, in a time where available
funding for mental healthcare is diminishing, evaluation
of the costs and benefits of CAT is necessary. With this
information available, mental health institutions will be
able to make well-considered decisions with regard to
the type of treatments and interventions that they offer.
Methods/Design
The methods and design of the intervention study are
described using the Consolidated Standards for Report-
ing Trials (CONSORT) statement and the extension for
reporting cluster randomized controlled trials [15].Design
This is a two-arm, multicenter, cluster randomized con-
trolled trial assessing CAT as a nursing intervention in
long-term residential patients with SMI. Patients in the
intervention group will receive CAT in addition to treat-
ment as usual ((TAU) CAT + TAU) and will be com-
pared to the control group who will only receive TAU.
Assessments take place at baseline and every three
months thereafter. This study has a duration of one year.
For the intervention group, four additional assessments
take place at 15, 18, 21 and 24 months in order to inves-
tigate the long-term effects.
The Medical Ethics Review Committee of the Univer-
sity Medical Center Groningen in the Netherlands ap-
proved the study design, research protocol, information
brochure and informed consent procedure (approval num-
ber M13.143271). The study is funded by a NutsOhra
grant (grant number: 1303–041).
Recruitment and inclusion of patients
A total of 100 long-term residential patients suffering
from SMI will be included in the study. Patients who
participated in the pilot study or patients who are under
18 years of age are excluded from participation. There
are no other criteria held.
Patients are recruited from the long-stay departments
of three institutions in the Netherlands: Lentis Psychiatric
Institute (Zuidlaren), Dijk en Duin Psychiatric Institute
(Castricum) and GGZ Drenthe (Assen). The departments
typically provide long-term pharmacological and psycho-
social treatment and focus on rehabilitation and recovery
for adult SMI patients. Admitted patients have often insuf-
ficiently recovered during several previous hospitalizations
and/or periods of sheltered living, and experienced educa-
tional, vocational and social problems early in life. The
majority of the patients suffer from psychotic disorders.
Other diagnoses include severe major depression, person-
ality disorders, bipolar disorder and autism.
Patients are informed about the study by nurses from
the concerning department. Patients are informed that
participation is voluntary and that they are free to with-
draw at any time without providing a reason and without
consequence for the usual treatment. Questions can be di-
rected at the nurses or the researchers (contact informa-
tion is provided in a patient folder). Participants are
required to provide written informed consent at baseline.
Sample size calculation
This sample size is based on a power analysis using the
effect size (0.79) calculated from Multnomah Commu-
nity Ability Scale (MCAS) scores from our pilot study
[12]. To detect a significant change in daily functioning
measured by the MCAS with α set at 0.05 and a power
of 0.9, 35 patients should complete the intervention.
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interventions in psychiatric patients can be substantial.
Therefore we have taken into account a conservative
drop-out rate of 30% and will include at least 50 patients
in each condition. Analyses are performed when both
groups completed the assessments at 12 months and at
the study end when follow-up assessments of the inter-
vention group have been completed (24 months).
Randomization
With regard to the randomization procedure, several is-
sues were to be considered. Each location employed sev-
eral nursing teams, with separate offices, patient units
and caseloads. Cluster randomization was applied on a
nursing team level for each of the three institutions. This
resulted in an equal distribution in the number of nursing
teams allocated to CAT and TAU within each institution.
Not only does this approach prevent contamination be-
tween nurses in the intervention and control groups, it
also enhances implementation of the intervention since all
nurses within each intervention team are trained in CAT
and regular nursing meetings can be used for informing
colleagues about the progression of the intervention. The
nursing teams are randomly allocated to either the inter-
vention or the control group by an independent staff
member (without interest in or knowledge about the out-
come of the allocation) who blindly draws a ticket from a
basket containing a CAT ticket and a blank ticket. No in-
clusion or exclusion criteria are applied for nurses.
Cognitive adaption training nurses and specialists
Nurses in the intervention teams are responsible for set-
ting up and evaluating the intervention for a maximum
of one to three patients, while all nurses are responsible
for supporting the daily use of interventions of all pa-
tients. Hereafter, the term CAT case manager refers to
the former role, while the term nurse refers to the general
tasks of all nurses in the team. CAT specialists are profes-
sionals educated to at least bachelor level, who have know-
ledge about the relationship between cognition and
general functioning, and who are knowledgeable with re-
gard to the underlying principles of CAT. Besides super-
vising CAT case managers in the development and
implementation of the intervention for each individual pa-
tient, CAT specialists guard the underlying principles of
CAT in the interventions that are applied. CAT specialists
APMS and JER, both psychologists at Lentis Psychiatric
Institute, were trained by Dr Velligan, the developer of
CAT. They provided additional training for CAT special-
ists at the other institutions.
Blinding
Blinding will take place at the level of assessors of out-
come variables. Blinding of patients and nurses is notpossible due to the nature of the intervention. Similarly,
blinding of the researcher is not possible due to the re-
searcher’s (APMS) role in the training of nurses and
CAT meetings with nurses. Research assistants (psych-
ology students educated to at least bachelors level) are
trained to administer the assessments. They are blind to
the treatment arm in which the patient is included and
do not receive any information with regard to the con-
tent and aims of the intervention. Nurses and patients
are requested not to disclose any information about the
allocation of conditions or the content of the interven-
tion to the students. Students are instructed to inform
the researcher immediately when they suspect blinds are
broken, in which case the measurement is finished by
another student who is still blind to the allocation of the
patient. Furthermore, guessing of the allocation group
by raters after each assessment will be used to evaluate
whether blinding was successful.
Tests and measures
Testing procedure
All participants (intervention and control group) are mea-
sured at baseline and after three, six, nine and 12 months.
Additionally, to determine whether any obtained results in
the intervention group can be retained, follow-up assess-
ments are planned after 15, 18, 21 and 24 months. Al-
though CAT is not designed to alter cognitive functioning
(rather to bypass cognitive problems) nor to improve
symptoms, cognitive functioning and symptomatology are
measured again at six and 12 months to evaluate any un-
expected changes. The schedule of enrollment, interven-
tions and content of the assessments is shown in Table 1.
For all patients, interviews and cognitive tests are assessed
in separate sessions. In the intervention group, environ-
mental and functional problems in everyday functioning
are assessed in an additional session. Level of everyday
functioning is chosen as the primary outcome. All tests
and measures are described below. Secondary outcome
measures are quality of life, empowerment and apathy. As-
sessment outcomes for the control group will not be used
in their treatment plan for the duration of the trial.
Demographical information
Demographical information (date of birth, gender, na-
tionality, level of education, main diagnosis, comorbid
diagnoses, age of onset, psychiatric disorders of parents
and siblings, relevant medical events, neurological disor-
ders and alcohol and drug use) is partly obtained from the
patient file and completed at baseline assessment (T0).
Severity of current psychotic symptoms
The presence and severity of psychotic symptoms is
measured using the Positive and Negative Syndrome
Scale (PANSS) [16] by trained blind raters (psychology
Table 1 Schedule of enrollment, interventions and assessments
Study period
Intervention period Follow-upb





Control (TAU) X X X X X
Intervention (TAU + CAT)c X X X X X X X X X
Assessments:
Environmental/functional problemsb and behavior type X
Clinical and cognitive characteristics X X X
Demographical information X
Everyday functioning X X X X X X X X X
Quality of life and empowerment X X X
Apathy X X X
Healthcare costs X X X X X X X X X
aNumber illustrates number of months after baseline.
bAssessed for the intervention group only.
cAbbreviations: TAU treatment as usual, CAT Cognitive Adaptation Training.
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is a semi-structured interview that consists of three sub-
scales: positive symptoms, negative symptoms and general
psychopathology. The PANSS is a widely used instrument
with good psychometric properties [16]. The PANSS is ad-
ministered for patients with a psychotic disorder or a dis-
order with psychotic features only.
Behavior type
The Frontal Systems Behavior Scale (FrSBe) [17], which
is filled out by the CAT case manager, is used to determine
the behavior type. This scale consists of 46 statements on
apathy, disinhibition and executive functioning. Each
statement can be scored on a scale ranging from one (al-
most never) to five (almost always). The apathy and disin-
hibition scores determine whether the patient’s behavior
type is best characterized as apathy, disinhibition or mixed
(combination of apathy and disinhibition).
Executive functioning
The level of executive functioning is determined with
the Modified Card Sorting Test (MCST) [18] and the
letter fluency task [19]. The perseveration and categories
score of the MCST and the total score of the letter flu-
ency task are used to determine the level of executive
functioning. A division is made between poor (problems
with planning and performing the steps of basic every-
day tasks such as showering and dressing) and fair
(problems on higher level functions, such as manage-
ment of money and work skills). When the participant isnot able or willing to participate in the tests, the score
on the executive subscale of the FrSBe is used to deter-
mine the level of executive functioning.
Cognitive strengths and weaknesses
Complementary cognitive tests are administered to de-
termine strengths and weaknesses in visual attention
(Picture Completion; Wechsler Adult Intelligence Scale
IV (WAIS-IV)) [20], auditory attention (Digit Span for-
ward; WAIS-IV) [20], working memory (Digit Span
Backward; WAIS-IV) [20] and verbal short term mem-
ory (Word Learning Task) [21]. Strengths and weak-
nesses in auditory attention and working memory are
determined with cut-off scores identical to those used by
Dr Velligan (personal communication, A.P.M. Stiekema)
(auditory attention: <4 = weak, >7 = strong and 4 to 7 =
average; working memory: <2 = weak, >5 = strong and 2
to 5 = average). For visual attention, we use transformed
raw scores to scale scores on the picture completion task
according to the Dutch norms [20] and set cut-off points
for the scale scores (<5 = weak, >10 = strong and 5 to 10 =
average). Finally, for verbal short term memory, we use
the available Dutch norms [21] to set cut-off points at per-
centiles (<25 = weak, >50 = strong and 25 to 50 = average).
Environmental and functional assessment
The individual problems with everyday functioning are
assessed with the Environmental and Functional Assess-
ment (EFA) by Velligan et al. [10]. The EFA is an exten-
sive interview on daily activities, functional skills and the
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We slightly adjusted the EFA so that the given examples
reflect situations that are common for the study popula-
tion in the Netherlands. In addition, we now explicitly
ask for the patient’s wishes with regard to the every
tasks. The EFA is administered in the patient’s residence
by a CAT specialist together with the CAT case manager.
If necessary, the CAT case manager supports the patient
in answering the questions during the interview.
Everyday functioning
Level of everyday functioning is measured with a num-
ber of instruments. First, the Multnomah Community
Ability Scale (MCAS) [22] is used to enable us to com-
pare results with previous CAT studies. The MCAS is a
semi-structured interview containing 17 items and as-
sesses a variety of domains of community adjustment.
As reports of mental healthcare professionals who are in
frequent contact with patients tend to be more linked to
performance on everyday tasks than self-reports [23], a
comparison of patients’ reports and nurses’ observations
(measured with observational questionnaires described
below) is used to determine possible discrepancies be-
tween answers and to adapt MCAS scores if necessary.
The instrument was translated into Dutch (PQ) and
back-translated by a professional translator. The English
version has proven to be reliable and valid [24].
The second instrument used to measure everyday
functioning is the Social and Occupational Functioning
Scale (SOFAS) [25]. The SOFAS is a reliable and valid
instrument for measuring social, occupational and inter-
personal functioning on a single-item scale (range: 0 to
100) [26].
Third, engagement in work-related activities is used as
an indication of everyday functioning. Engagement in
work-related activities is measured in number of partial
days a week (a partial day consists of three hours) and is
registered daily by the staff.
Finally, two observational questionnaires are filled out
by a nurse (the CAT case manager in the intervention
group; for the intervention group individual nurses are al-
located between one and three patients for whom to
complete the observational questionnaires). The Social
Functioning Scale-other (SFS) [27] measures functioning
in society. It contains seven subscales: (1) social engage-
ment, (2) interpersonal behavior, (3) pro-social activities, (4)
recreation, (5) independence-competence, (6) independence-
performance and (7) employment and/or occupation. The
SFS has good psychometric properties [27]. The second
observational questionnaire is the Life Skills Profile (LSP)
[28]. The LSP is a questionnaire consisting of 39 questions
on a four-point scale (lower scores indicate better life
skills) and measures a range of aspects related to success-
ful community or hospital living: (1) self-care, (2) non-turbulence, (3) social contact, (4) communication and (5)
responsibility. The scale has shown good psychometric
properties when completed by case workers and residen-
tial staff [29].Quality of life
Quality of life is measured with the Short Form Health
Survey (SF-12) [30]. The SF-12 is a self-report question-
naire with 12 items measuring subjective physical, psy-
chological and social well-being. The SF-12 has good
psychometric properties for use in SMI populations [31].Empowerment
Empowerment is measured by a self-report question-
naire, the Dutch Empowerment Questionnaire ((DEQ)
Nederlandse Empowerment vragenLijst) [32]. Three of
the six subscales are used in the current study, namely
professional help, self-knowledge and belonging. Items
are scored on a five-point scale ranging from one
(strongly disagree) to five (strongly agree). The validity
and reliability of the DEQ is sufficient [32].Apathy
The avolition-apathy subscale of the Scale for the As-
sessment of Negative Symptoms (SANS) [33] is adminis-
tered to measure apathy. The four items of this subscale
can be rated from 0 (absent) to four (severe). The SANS
is a valid and reliable instrument [34].
Motivation to engage in activities is assessed using the
motivation subscale from the Negative Symptom Assess-
ment, a semi-structured interview (NSA-16) [35]. The
motivation subscale contains four items that can be rated
from one (no evidence of this symptom) to six (severe).
The validity and reliability of the NSA-16 is good [36].Treatment as usual
Although the institutions vary somewhat in the treat-
ments they offer, all patients have access to pharmaco-
therapy. The range of psychological, psychosocial and
non-verbal therapies (such as psycho-education, cogni-
tive behavioral therapy, Liberman training, peer support
groups, psychomotor therapy, music therapy, creative
arts therapy and sports groups), as well as educational or
work projects (such as a framing center, graphic design
and copy center, a farmhouse, catering and site and gar-
den maintenance) differs somewhat between locations,
which will be accounted for in the analyses. For each pa-
tient, treatment is aimed at a combination of therapies
and daily activities that best matches the needs, goals
and wishes of the patient in order to reach an optimal
recovery process. Treatment and progress are evaluated
at least once per year.
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Preparation: training of nurses and cognitive adaptation
training specialists
To optimize the implementation of CAT and to ensure
CAT would be included in the working routine, all
nurses in the intervention groups were trained in CAT,
though not screened for eligibility. Nurses participate in
a didactical group training prior to the recruitment of
patients. The training is delivered by the CAT specialists
who were trained in CAT by Dr Velligan, the developer
of CAT (APMS and JER). Translated PowerPoint presen-
tations and video demonstrations of Dr Velligan serve as
the basis of the didactical training, to ensure fidelity to
the CAT treatment model. The didactical training in-
cludes the theoretical background and principles, assess-
ments, use of the CAT manual, intervention strategies,
CAT visits and continuity of the intervention. APMS
and JER provided an additional training on assessing the
EFA, composing the CAT treatment plan (see below)
and continuity of CAT in daily care for the CAT special-
ists at all intervention locations.
Designing the cognitive adaptation training treatment plan
The protocol developed by Dr Velligan and her group
(personal communication, A.P.M Stiekema, P.J. Quee) is
followed to design the CAT treatment plan, with some
minor modifications due to the availability of tests trans-
lated into Dutch. The CAT plan and starting point of
the intervention is based on: (1) behavior type, (2) level
of executive functioning, (3) goals for improving every-
day functioning and (4) cognitive strengths and weak-
nesses that are assessed at T0. Upon completion of this
assessment, a CAT specialist summarizes the outcomes
of the cognitive assessment and discusses these with the
CAT case manager during the first CAT meeting. Based
on the wishes and problems reported by the patient dur-
ing the EFA, the CAT specialist and the CAT case man-
ager discuss the priority of problems and make an initial
priority of goals that may be targeted with the interven-
tion. In the next step of the intervention process, the
CAT case manager discusses the assessments with the
patient during the first CAT visit. The patient is encour-
aged to formulate their own goal, however if they are
unable to do so, the CAT case manager suggests a goal
according to the priority of the initial CAT plan. If ne-
cessary, the priority on the CAT plan is adapted follow-
ing the wishes of the patient after the first or subsequent
CAT visits.
Implementing the cognitive adaptation training treatment
plan
Once the CAT treatment plan is formed and discussed
with the patient, the CAT specialist and CAT case man-
ager discuss possible interventions using the CAT manualand taking individual characteristics into account. Possible
intervention strategies are discussed and set up together
with the patient when in any way possible. Intervention
strategies are limited to one goal at a time to ensure pa-
tients are not faced with more than they can handle. After
the first intervention the CAT case manager is responsible
for setting up and organizing environmental supports and
evaluating the interventions with the patients in their
caseload. CAT visits to the patients are planned within the
daily routine of the nurses. Based on our pilot study, a dur-
ation of CAT visits of approximately 45 minutes a week
per patient in total (time may be divided over a number of
CAT visits) is deemed to be sufficient. In addition, the
CAT case manager makes a record of the CAT visits in the
patient file, based upon four questions: what interventions
worked, what interventions did not work, what changes
are made in the intervention strategies and what issues
need to be kept in mind.
During the implementation phase (one to two months),
the CAT specialist and CAT case manager plan CAT dis-
cussion meetings at least once a month. The nursing team
as a whole is informed of, and responsible for, and sup-
ports the daily use of the interventions of all patients (for
example, checking and reporting on whether a recorded
message leads to the targeted behavior, or changing a
weekly checklist). In the securing phase (up to 12 months),
CAT group meetings are incorporated into regular staff
meetings for at least another six months, to stimulate the
exchange of knowledge and interventions between nurses.
Finally, after the securing phase (after 12 months), a CAT
focus group including the researchers and clinicians
(APM, JER and LM) and a delegation of nurses, will deter-
mine the form and frequency of CAT meetings in the
follow-up phase (12 to 48 months).
Statistical analysis plan
Primary and secondary outcomes
Mean differences in the outcomes between the interven-
tion and control group will be investigated by applying a
marginal linear mixed model (modeling mean scores for
both groups) using restricted maximum likelihood esti-
mation to the outcomes at each time point after base-
line. The analyses are corrected for baseline scores to
eliminate the effect of possible (average) differences be-
tween the intervention and control group at baseline.
The treatment effect is essentially estimated for each
time point by subtracting the estimated mean scores of
the control group from the estimated mean scores of the
intervention group, reflecting the estimated mean differ-
ence between the groups over time.
Sub-analyses will be performed to evaluate individual
improvement in everyday functioning. To this end, we
will specifically evaluate only those items of the MCAS,
SFS and LSP that measure the domain(s) that are recorded
Stiekema et al. Trials  (2015) 16:49 Page 8 of 10as goals in the CAT treatment plan. That is, we will evalu-
ate whether patients have indeed improved on the activ-
ities they have been working on with CAT, and for which
individually tailored interventions were set up. Sum scores
of items of the LSP, and SFS reflecting a certain goal will
be computed. Differences in these sum scores over time
will reflect whether patients’ performance on these do-
mains have improved, did not change or have deteriorated.
Generalized linear models will be used to determine
whether there is a statistically significant proportion of im-
provement target behaviors compared to no change or
deterioration.
Economic evaluation
An economic evaluation will be conducted alongside the
clinical study to assess the balance between costs and
health outcomes of CAT + TAU compared to TAU.
Healthcare consumption and costs
This study is conducted from a healthcare perspective,
since costs within the healthcare system are most rele-
vant for the current study population. Medical costs that
will be assessed include costs of the interventions (costs
of personnel, materials and housing), inpatient care and
medication use. In order to calculate costs, Dutch stand-
ard prices for each cost unit [37] are combined with
information on healthcare consumption. Healthcare con-
sumption will be prospectively registered for all the in-
cluded patients by means of a detailed questionnaire
adapted to the context of the current study. This question-
naire is completed by each CAT case manager at baseline
and at three, six, nine and 12 months for both groups and
at 15, 18, 21 and 24 months for the intervention group.
Cost-effectiveness and cost-utility analysis
The primary outcome measure of the planned cost-
effectiveness analysis (CEA) is the MCAS. Results of the
CEA are expressed in terms of incremental costs per
point change in MCAS score. Furthermore, a cost-utility
analysis will be conducted with quality adjusted life years
(QALY) as the primary outcome measure. In order to
estimate QALYs, utility scores are derived from the SF-12
[38]. The uncertainty surrounding the cost-effectiveness
and cost-utility ratios will be estimated by bootstrap ana-
lyses. In addition, cost-effectiveness acceptability curves
will be used to inform decision-makers on the probability
that CAT is cost-effective.
Discussion
In SMI care, especially in the chronic stage of the dis-
ease, there is a necessity for practical hands-on interven-
tions that target the functional impairments resulting
from cognitive deficits in such a way that functional im-
provements are made, and can also be sustained after astudy period. Primarily the latter aspect made us choose
an intervention that can be applied by those healthcare
professionals who support patients in their daily routine,
namely psychiatric nurses. The current, multicenter,
cluster randomized controlled trial meets with these
needs by assessing the efficacy of CAT as a nursing
intervention on everyday functioning in residential pa-
tients with SMI. We hypothesize that CAT as a nursing
intervention leads to improvements in everyday func-
tioning (primary outcome) and apathy, and thereby in
quality of life and empowerment (secondary outcomes).
A strength of this study is that patients are recruited
from multiple psychiatric institutions spread across the
Netherlands, increasing representativeness and thus in-
creasing generalizability. An additional strength is that it
addresses the long-term effects of the intervention (up
to two years). The length of the study takes into account
that rehabilitation in long-term residential patients is a
slow process [39]. Furthermore, by following up on
everyday functioning for up to two years (one year after
completion of the study), we will evaluate whether CAT
has been successfully incorporated in the working rou-
tine of nurses. This is important because the nurses will
have to provide ongoing support to sustain improve-
ments. Another strength is that the outcomes of every-
day functioning are not solely based on self-reports, but
are also assessed by the number of work-related activ-
ities per week, and by observational questionnaires that
are filled out by the CAT case manager. As such, we use
various measures to substantiate our impression of the
level of everyday functioning of the patients. Further-
more, this approach allows us to collect data even if the
patient misses an assessment. Finally, because of our
choice not to hold common eligibility criteria, for ex-
ample with regard to diagnosis or (prior) comorbid psy-
chiatric or somatic disorders, our results will be better
generalizable to the whole SMI population, instead of
only pertaining to schizophrenia patients. This is import-
ant since it increases the clinical importance and exter-
nal validity of our findings.
Possible weaknesses of the study are the lack of mea-
surements focusing on the nurses who carry out the
intervention. Motivation, self-efficacy and empowerment
of the nurses may mediate the effect of the intervention,
but an absence of appropriate instruments in this regard
leaves us unable to take these aspects into account.
Moreover, there are few instruments that are specifically
designed for measuring everyday functioning of patients
residing in long-stay clinical facilities, whose problems
and needs may differ from patients living in the commu-
nity. Finding a suitable instrument is further complicated
by the fact that areas for interventions are individually
determined and therefore differ for each patient. Due to
the global nature of the measures of everyday functioning,
Stiekema et al. Trials  (2015) 16:49 Page 9 of 10our instruments may not be sensitive enough to assess im-
provements because CAT aims to improve one or two
areas of functioning at a time. For this reason, we included
the additional sub-analyses in the statistical analysis plan
that specifically evaluate improvements in targeted do-
mains (as described in the statistical analysis section).
If evidence yields support for CAT, this may fulfill a
need for a hands-on intervention that can contribute to
the functional recovery of patients living in long-stay
clinical facilities.
Trial status
Recruitment is currently ongoing. Patient enrollment
started in September 2013 and will continue until 100
patients are included in the study.
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